According to GenSight Biologics's latest financial reports the company's current earnings are A$1.56 Million. In 2024 the company made an earning of -A$22.72 Million, an increase over its 2023 earnings that were of -A$45.26 Million. The earnings displayed on this page is the company's Pretax Income.